LightForce Orthodontics has appointed Erica Rogers as its new CEO, with the company looking ahead to its next phase of commercial growth.
Rogers, a medtech industry veteran, will be tasked with scaling the company's 3D printing-enabled Generative Braces system beyond the 200,000 patients already treated. The LightForce Generative Braces system combines doctor-directed digital treatment planning, patient-specific ceramic and metal appliances, direct 3D printing, and guided placement.
Previously, Rogers was CEO of Silk Road Medical, which went public in 2019 and was subsequently acquired by Boston Scientific. She has also served on the LightForce board of directors for the past two years, working closely with the company’s leadership team, employees, customers, and investors.
“LightForce has reached an extraordinary moment in its journey,” said Rogers. “The company has proved it can operate at commercial scale and earned the trust of orthodontists who are redefining how treatment is delivered. Our focus now is to scale that impact and advance orthodontics toward a new standard of care.”
Rogers succeeds LightForce founder Alfred Griffin, DMD, PhD, MMSc, who founded the company on the premise that orthodontic brackets should be personalised to the patient.
Griffin will remain Chairman of the Board and, in his new role as Chief Product Pfficer, continue to lead the company’s innovation roadmap, product portfolio and category advocacy. He will also work to strengthen LightForce’s presence in orthodontic practices and teaching institutions while partnering closely with Rogers on the company’s strategy and growth.
“LightForce’s success has created an opportunity to expand under a leader with Erica’s experience scaling medical technologies, building organisations and establishing new categories of patient care,” Griffin said. “Having worked closely with her for two years, I know Erica is the right leader to accelerate the availability and adoption of generative braces and multiply what our talented team has already built.”
“I’ve known Erica for many years and first partnered with her during the growth of Silk Road Medical,” said Kevin Reilly, Managing Director and Head of Medtech at Ally Bridge Group, and a member of the LightForce board of directors. “I saw her ability to build exceptional teams, execute with discipline, and convert breakthrough technology into category leadership. Her leadership positions LightForce to scale generative braces adoption and compound value for patients, customers, employees, and investors.”
